Long-term outcome with respect to progression-free survival, overall survival, and relapse rate is superior after auto-allo compared with auto only.
Tandem Autologous/Reduced-Intensity Conditioning Allogeneic ...
ascopubs.org › doi › JCO.2010.32.7312
HDT with autologous stem-cell transplantation (ASCT) is part of the first-line standard treatment in patients up to the age of 65 years on the basis of the ...
Jun 20, 2013 · Tandem autologous/reduced-intensity allogeneic transplantation is superior to autologous transplantation alone in multiple myeloma. Abstract.
358 myeloma patients from 26 European centres were included in a prospective study comparing ASCT-RIC versus ASCT based on the availability of an HLA identical ...
Allogeneic hematopoietic cell transplantation (HCT) may improve long-term multiple myeloma (MM) control through graft vs myeloma (GVM) effect.
Allogeneic hematopoietic cell transplant (HCT) may improve long-term multiple myeloma (MM) control through the graft-versus-myeloma effect.
Oct 18, 2023 · Auto-allo-SCT seemed to be associated with improvements in PFS and CR when compared to tandem-auto-SCT in patients with HRMM, but it did not lead to a ...
Feb 1, 2019 · Our study showed that tandem autologous/minimal intensity allogeneic HCT for MM was safe and characterized by low acute and long-term toxicities.
People also ask
What is the difference between autologous stem cell transplant and allogeneic stem cell transplant?
Which is better autologous or allogeneic?
What is a tandem transplant for myeloma?
What are the disadvantages of autologous stem cell transplant?
Jun 20, 2013 · Long-term outcome in patients with multiple myeloma was better with auto/RICallo as compared with auto only and the auto/RICallo approach seemed to overcome ...
Nov 9, 2023 · AlloTSCT followed by thalidomide maintenance reduced the rate of recurrence or progression during a follow-up period of up to 10 years but failed to improve ...